What's in Napp Pharmaceuticals Limited's pipeline?

Napp Pharmaceuticals Limited has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Napp Pharmaceuticals Limited's portfolio?

Top competitors by shared drug class: Albany Medical College, Albert Einstein College of Medicine, Barrie Urology Associates, Children's Hospitals and Clinics of Minnesota, Daewon Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/napp-pharmaceuticals-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Napp Pharmaceuticals Limited — Portfolio Competitive Intelligence Brief

Napp Pharmaceuticals Limited pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Codeine paracetamol	Codeine paracetamol	marketed	Opioid analgesic combination	Opioid receptors (μ, δ, κ); cyclooxygenase (COX-1, COX-2)	Pain Management

Therapeutic area mix

Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Albany Medical College · 1 shared drug class
Albert Einstein College of Medicine · 1 shared drug class
Barrie Urology Associates · 1 shared drug class
Children's Hospitals and Clinics of Minnesota · 1 shared drug class
Daewon Pharmaceutical Co., Ltd. · 1 shared drug class
Henry Ford Health System · 1 shared drug class
Janssen Korea, Ltd., Korea · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Napp Pharmaceuticals Limited:

Cite this brief

Drug Landscape (2026). Napp Pharmaceuticals Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/napp-pharmaceuticals-limited. Accessed 2026-05-16.